Home > Insider Trading > Filing (0001127602-17-003867)

Filing Details

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
64803	Cvs Health Corp	CVS	Retail-Drug Stores And Proprietary Stores (5912)	050494040

Insiders

Cik	Name	Reported Address	Insider Title	Director	Officer	Large Shareholder	Other
1194413	J Larry Merlo	One Cvs Drive Woonsocket RI 02895-	President And Ceo	Yes	Yes	No	No

Reported Non-Derivative Transactions

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
Common Stock	Acquisiton	2017-02-01	76,494	$36.23	318,706	No	4	M	Direct
Common Stock	Disposition	2017-02-01	76,494	$78.32	242,212	No	4	S	Direct

Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
No	4	M	Direct
No	4	S	Direct

Reported Derivative Transactions

Sec. Name	Sec. Type	Acquisiton - Disposition	Date	Amount	Price	Amount - 2	Price - 2
Common Stock	Stock Option	Disposition	2017-02-01	76,494	$0.00	76,494	$36.23

Remaning Holdings	Exercise Date	Expiration Date	Equity Swap Involved	Transaction Form Type	Transaction Code	Nature of Ownership
0	2011-04-01	2017-04-01	No	4	M	Direct

Reported Non-Derivative Holdings

Sec. Name	Remaning Holdings	Nature of Ownership	Explanation
Common Stock	360,627	Indirect	By Trust As Beneficiary
Common Stock (Restricted)	209,398	Direct
Esop Common Stock	6,643	Indirect	By ESOP
Stock Unit	605,988	Direct

Reported Derivative Holdings

Sec. Name	Sec. Type	Price	Date	Expiration Date	Amount	Remaning Holdings	Nature of Ownership
Common Stock	Phantom Stock Credits	$1.00			5,131	5,131	Direct
Common Stock	Stock Option	$34.96	2012-04-01	2018-04-01	241,150	241,150	Direct
Common Stock	Stock Option	$45.07	2013-04-02	2019-04-02	332,736	332,736	Direct
Common Stock	Stock Option	$54.53	2014-04-01	2020-04-01	314,713	314,713	Direct
Common Stock	Stock Option	$74.29	2015-04-01	2021-04-01	335,697	335,697	Direct
Common Stock	Stock Option	$102.26	2016-04-01	2022-04-01	273,929	273,929	Direct
Common Stock	Stock Option	$104.82	2017-04-01	2023-04-01	286,787	286,787	Direct

Expiration Date	Amount	Remaning Holdings	Nature of Ownership
	5,131	5,131	Direct
2018-04-01	241,150	241,150	Direct
2019-04-02	332,736	332,736	Direct
2020-04-01	314,713	314,713	Direct
2021-04-01	335,697	335,697	Direct
2022-04-01	273,929	273,929	Direct
2023-04-01	286,787	286,787	Direct

Footnotes

All sales were effected pursuant to a Rule 10b5-1 plan.
Represents weighted average sale price for this trading day. Multiple sales were executed, with sales prices ranging between $77.75 and $79.10 per share.
Option became exercisable in three equal annual installments, commencing 4/1/2011.
Each share credit is equivalent to one share; 1-for-1 conversion.
Reflects year end company match share credits under a non-qualified deferred compensation plan; share credits are payable in cash only, at such time as has been elected by the reporting person.
Reflects year end company match share credits under a non-qualified deferred compensation plan; share credits are payable in cash only, at such time as has been elected by the reporting person.
Option became exercisable in four equal annual installments, commencing 4/1/2012.
Option became exercisable in four equal annual installments, commencing 4/2/2013.
Option became exercisable in four equal annual installments, commencing 4/1/2014.
Option became exercisable in four equal annual installments, commencing 4/1/2015.
Option became exercisable in four equal annual installments, commencing 4/1/2016.
Option becomes exercisable in four equal annual installments, commencing 4/1/2017.